Related Experiment Video

Updated: Feb 6, 2026

Gene Transfer for Ischemic Heart Failure in a Preclinical Model
07:35

Gene Transfer for Ischemic Heart Failure in a Preclinical Model

Published on: May 15, 2011

13.4K

Potential targets of gene therapy in the treatment of heart failure

Jakub Rosik1, Bartosz Szostak1, Filip Machaj1

  • 1a Department of Physiology , Pomeranian Medical University , Szczecin , Poland.

Expert Opinion on Therapeutic Targets
|August 21, 2018
PubMed

Insights

Gene therapy offers a promising new avenue for treating heart failure (HF) by targeting specific genes involved in calcium regulation. Researchers are exploring targets like SERCA2a, S100A1, and IPP-1 to improve patient outcomes.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Genetics

Background:

  • Heart failure (HF) is a widespread condition with significant mortality and healthcare costs.
  • Current pharmaceutical treatments for HF remain unsatisfactory.
  • Ischemic heart disease often necessitates invasive treatments impacting quality of life.

Purpose of the Study:

  • To review advances in gene therapy for heart failure.
  • To identify molecular targets for novel HF treatments.
  • To discuss gene targets regulating calcium concentrations and SUMOylation.

Main Methods:

  • Literature review of gene therapy trials in HF.
  • Identification of potential therapeutic gene targets.
  • Analysis of genes involved in calcium regulation and gene expression.

Main Results:

  • SERCA2a, S100A1, and IPP-1 identified as potential therapeutic targets for HF.
  • Gene therapy is being investigated for its efficacy in HF treatment.
  • SUMOylation is another potential therapeutic approach.

Conclusions:

  • Gene therapy presents a viable treatment option for heart failure.
  • Targeting calcium regulation pathways shows promise.
  • Further research is needed to overcome challenges and improve HF prognosis.
Abstract

Keywords:
IPP-1S100A1SERCA2aSUMO1gene therapyheart failure

More Related Videos

Large Animal Model for Evaluating the Efficacy of the Gene Therapy in Ischemic Heart06:07

Large Animal Model for Evaluating the Efficacy of the Gene Therapy in Ischemic Heart

Published on: September 2, 2021

2.3K
Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

2.0K

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
348
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
628
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
964
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.8K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
903